|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$1.33 |
$1.33 |
$1.20 |
$1.24 |
4.72M | 04/22/2024 |
$1.31 |
$1.41 |
$1.29 |
$1.36 |
1.97M | 04/23/2024 |
$1.39 |
$1.43 |
$1.31 |
$1.42 |
1.10M | 04/24/2024 |
$1.37 |
$1.42 |
$1.37 |
$1.38 |
958.20K | 04/25/2024 |
$1.36 |
$1.37 |
$1.29 |
$1.32 |
1.05M |
|
Nektar Therapeutics is a research-based biopharmaceutical company. Co.'s research and development pipeline of investigational drugs includes potential therapies for oncology, immunology and virology. In oncology, Co. is studying several immuno-oncology drug candidates including bempegaldesleukin, NKTR-255 and NKTR-262. In immunology, Co. is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, Co.'s programs include studying bempegaldesleukin in treating individuals affected with COVID-19, and a preclinical research collaboration with Gilead Sciences Inc. to test the combination of NKTR-255. | |
|
Nektar Therapeutics (NKTR) has the following price history information. Looking back at NKTR historical stock prices for the last five trading days, on April 19, 2024, NKTR opened at $1.33, traded as high as $1.33 and as low as $1.20, and closed at $1.24. Trading volume was a total of 4.72M shares. On April 22, 2024, NKTR opened at $1.31, traded as high as $1.41 and as low as $1.29, and closed at $1.36. Trading volume was a total of 1.97M shares. On April 23, 2024, NKTR opened at $1.39, traded as high as $1.43 and as low as $1.31, and closed at $1.42. Trading volume was a total of 1.10M shares. On April 24, 2024, NKTR opened at $1.37, traded as high as $1.42 and as low as $1.37, and closed at $1.38. Trading volume was a total of 958.20K shares. On April 25, 2024, NKTR opened at $1.36, traded as high as $1.37 and as low as $1.29, and closed at $1.32. Trading volume was a total of 1.05M shares.
NKTR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Nektar Therapeutics shares, starting with a $10,000 purchase of NKTR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$11.49 |
|
End price/share: |
$1.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-88.51% |
|
Average Annual Total Return: |
-19.46% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,149.14 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $1.24 | 04/22/2024 | $1.36 | 04/23/2024 | $1.42 | 04/24/2024 | $1.38 | 04/25/2024 | $1.32 |
|
|